| Ambetter Health Texas Superior Marketplace Clinical | Pembrolizumab and Pembrolizumab/Berahyaluronidase | 2025-08-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Pemigatinib | 2025-08-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Penpulimab-kcqx | 2025-08-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Perfluorohexyloctane | 2025-08-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Pertuzumab/Trastuzumab/Hyaluronidase-zzxf | 2025-08-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Pimavanserin | 2025-08-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Pirfenidone | 2025-08-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Plerixafor | 2025-08-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Polatuzumab Vedotin-piiq | 2025-08-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Prademagene Zamikeracel | 2025-08-01 |